2026-08-24 · By SEPT AI
U.S. equities delivered a mixed performance Monday, with the Dow eking out a modest gain while the broader market retreated amid lingering concerns over growth valuations and a flurry of corporate headlines. The S&P 500 slipped 0.17%, while the tech-heavy Nasdaq-100 declined 0.48%, as investors digested a wave of earnings reports, regulatory filings, and strategic announcements.
## Market Overview
The Dow Jones Industrial Average, tracked by the DIA ETF, rose 0.34% to close at $533.62, recovering from its opening level of $531.83 and touching a high of $534.48 during the session. The blue-chip index managed to buck the broader trend, supported by strength in select industrial and financial names.
However, the broader market faced headwinds. The SPY, which tracks the S&P 500, closed at $763.48, down 0.17% from its open of $764.78. The QQQ, representing the Nasdaq-100, fell 0.48% to $706.28, with the session low reaching $702.70. Small caps underperformed, with the IWM declining 0.53% to $297.96.
The Fear & Greed Index stood at 73, firmly in "Greed" territory, suggesting investor sentiment remains elevated despite the day's mixed action.
## Sector Highlights
Technology and growth stocks bore the brunt of the selling pressure, as the QQQ's decline reflected ongoing rotation away from high-multiple names. The small-cap Russell 2000's 0.53% drop further underscored risk-off positioning in more speculative areas of the market.
Conversely, the Dow's resilience pointed to strength in more cyclical and value-oriented sectors, including industrials and financials, which benefited from insider buying activity and steady economic fundamentals.
## Biggest Movers
A dramatic session for individual names saw several stocks swing sharply on corporate developments.
DAIC surged 59.05% to $1.72 on massive volume of 71.5 million shares, though no specific catalyst was immediately identifiable from the data. TJGC jumped 32.25% to $6.11, while SUJA rose 17.34% to $9.07, BIVI gained 17.27% to $2.12, and JZ advanced 17.24% to $2.38.
On the downside, DFNS cratered 41.92% to $11.10, followed by FBDT falling 41.67% to $2.10. RPGL dropped 33.33% to $1.66, PSIG slid 23.23% to $2.28, and XPON tumbled 22.39% to $6.03 on heavy volume of nearly 56 million shares.
## Key Earnings
Gorilla Technology Group (GRRR) dominated the earnings headlines with a complex report. The company said FY2026 revenue is expected to exceed $200 million, above the $190.898 million estimate, sending shares higher initially. However, the stock faced headwinds after management guided FY2027 sales of $450 million to $500 million, below the $559.988 million consensus, and Q3 sales of $48 million to $50 million, well short of the $84.573 million estimate. On a positive note, Gorilla reported H1 adjusted EPS of $(0.58), beating the $(1.00) estimate, while sales of $78.4 million topped the $43.644 million forecast.
## Macro & Economic
No major economic data releases were highlighted in the day's news flow. The market's focus remained squarely on corporate developments and individual stock catalysts.
## Smart Money
Insider buying activity provided a notable undercurrent of confidence in several names. RSG saw 52 insiders purchase a staggering $548.9 million worth of stock, earning a STRONG_BUY score of 3. KKR had one insider buy $4.7 million, while MTN saw two insiders accumulate $5.0 million. HBAN recorded 15 insider buys totaling $1.4 million, and TXT had one insider purchase $988,594. BA saw two insiders buy $799,311, while WHR had one insider purchase $198,829. NVR recorded one insider buy of $73,694, and TSM saw 77 insiders accumulate $1.2 million. Even CPB had a small insider purchase of $2,145.
## Crypto
No specific cryptocurrency data or news was provided in today's market summary.
## Looking Ahead
Investors will be watching for continued earnings reactions, particularly from Gorilla Technology, as the market digests its mixed guidance. The FDA-related catalysts for BMEA (Phase II diabetes trial enrollment completion) and AMIX (pending patent grant) could drive further biotech sector action. Additionally, the Nasdaq non-compliance notices for HUBG and AIHS may keep those names in focus.
The broader market will also monitor any shifts in the Fear & Greed Index, which remains elevated, and whether the divergence between the Dow's strength and the Nasdaq's weakness persists. With no major economic data on the immediate horizon, corporate news and insider activity are likely to remain the primary drivers of near-term price action.
Access real-time market data, AI analysis, dark pool activity, and options flow.
Start Free Trial